Sampatrilat (Synonyms: UK-81252) |
| Catalog No.GC69856 |
Sampatrilat (UK-81252) is a potent orally active vasopeptidase inhibitor that inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). Sampatrilat has 12.4 times greater inhibition of C-domain ACE (Ki=13.8 nM) compared to N-domain ACE (Ki=171.9 nM). Sampatrilat (UK-81252) can be used for research related to chronic heart failure and blood pressure regulation.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 129981-36-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *